Digipath, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022
May 16, 2022 at 04:17 pm
Share
Digipath, Inc. reported earnings results for the second quarter and six months ended March 31, 2022. For the second quarter, the company reported sales was USD 0.604735 million compared to USD 0.63316 million a year ago. Net loss was USD 0.373596 million compared to net income of USD 0.018201 million a year ago.
For the six months, sales was USD 1.3 million compared to USD 1.13 million a year ago. Net loss was USD 0.663921 million compared to USD 0.372436 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
Hypha Labs, Inc., formerly Digipath, Inc., has developed technology that cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. This product has an exact, consistent potency containing all the natural compounds found in these fungi. Typically, it takes six-eight weeks to fully grow mushrooms, and using its technology, the production of the active ingredient is only seven-10 days. This natural product solves the dosing issue created by having to use whole mushrooms. The product is tasteless and gentler on the stomach and can be used sublingually for fast-acting results. The product allows the consumer to produce measurable active ingredients at home for mental and physical benefits. It provides Psilocybin Mushrooms, Button Mushrooms, Shiitake Mushrooms, Maitake Mushrooms, Reishi Mushrooms, Lion's Mane Mushrooms, Oyster Mushrooms, Oyster Mushrooms and Crimini Mushrooms.
HYPHA LABS, INC. 